Target IL-13 x TSLP therary(Vial Health Technology Inc)

N/A

Report date: 2025/10/30 17:58:28

Base Information

Drug NameTarget IL-13 x TSLP therary(Vial Health Technology Inc)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionInterleukin-13 modulatorsThymic stromal lymphopoietin modulators

TargetsInterleukin-13Thymic stromal lymphopoietin

Therapy Area/IndicationsDermatitis, AtopicAsthmaSinusitis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesVial Health Technology Inc

China Registration ClassN/A

Develop Information

Active CompaniesVial Health Technology Inc

Inactive CompaniesN/A

Active IndicationsDermatitis, AtopicAsthmaSinusitis

Inactive IndicationsN/A

Other Information

ATC CodeN/A